TFGT
BDTX icon

TS Financial Group (TSFG)’s Black Diamond Therapeutics BDTX Stock Holding History

TS Financial Group (TSFG)’s Portfolio BDTX Stock Details BDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Hold
100
– – ﹤0.01% 851
2026
Q1 		$0 Hold
100
– – ﹤0.01% 819
2025
Q4 		$0 Hold
100
– – ﹤0.01% 816
2025
Q3 		$0 Hold
100
– – ﹤0.01% 828
2025
Q2 		$0 Hold
100
– – ﹤0.01% 812
2025
Q1 		$0 Hold
100
– – ﹤0.01% 802
2024
Q4 		$0 Hold
100
– – ﹤0.01% 745
2024
Q3 		$0 Hold
100
– – ﹤0.01% 778
2024
Q2 		$0 Hold
100
– – ﹤0.01% 760
2024
Q1 		$1K Hold
100
– – ﹤0.01% 704
2023
Q4 		$0 Hold
100
– – ﹤0.01% 894
2023
Q3 		$1K Hold
100
– – ﹤0.01% 892
2023
Q2 		$1K Hold
100
– – ﹤0.01% 886
2023
Q1 		$0 Hold
100
– – ﹤0.01% 958
2022
Q4 		$0 Hold
100
– – ﹤0.01% 973
2022
Q3 		$0 Hold
100
– – ﹤0.01% 955
2022
Q2 		$0 Hold
100
– – ﹤0.01% 981
2022
Q1 		$0 Hold
100
– – ﹤0.01% 920
2021
Q4 		$1K Hold
100
– – ﹤0.01% 806
2021
Q3 		$1K Buy
+100
New +$987 ﹤0.01% 789

Other funds holding BDTX

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

TS Financial Group (TSFG)'s BDTX Position: Q2 2026 in Review

TS Financial Group (TSFG) held its Black Diamond Therapeutics (BDTX) position steady in Q2 2026 at 100 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #851.

TS Financial Group (TSFG) first reported a position in BDTX in Q3 2021 and has held it in 20 quarters since. The position peaked at $1K in Q1 2024. 96 funds tracked by Wall St. Rank hold BDTX as of Q2 2026.

  • TS Financial Group (TSFG) held 100 shares of Black Diamond Therapeutics worth $0 as of Q2 2026.
  • TS Financial Group (TSFG) left its Black Diamond Therapeutics share count unchanged in Q2 2026.
  • Black Diamond Therapeutics made up ﹤0.01% of TS Financial Group (TSFG)'s portfolio in Q2 2026, its #851 holding.
  • TS Financial Group (TSFG) first reported a position in Black Diamond Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • TS Financial Group (TSFG)'s Black Diamond Therapeutics position peaked at $1K in Q1 2024.
  • 96 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q2 2026.

Based on TS Financial Group (TSFG)'s 13F filing for Q2 2026, filed 23 Jul 2026.